1 unknown. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow defactinib: new trials by email Literature Review of defactinib trials Research Report on defactinib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of FAK (Defactinib) and PD-1 (Pembrolizumab) Inhibition in Advanced Solid Malignancies (FAK-PD1) Defactinib, Pembrolizumab - Carcinoma, Non-small-cell Lung, Mesothelioma | Phase 1 / Phase 2 | Unknown | NHS Greater Glasgow and Clyde | 59 | 2017-07-04 | 2018-03-19 |
Carcinoma, Non-Small-Cell Lung (1) · Mesothelioma (1) · Pancreatic Neoplasms (1)
NHS Greater Glasgow and Clyde (1)
United Kingdom (1)
Christian Ottensmeier (1) · Dean Fennell (1) · Jeff Evans (1) · Stefan Symeonides (1) · Vicky Coyle (1)
2015 (1)